InvestorsHub Logo

DaubersUP

04/09/19 8:45 AM

#259912 RE: PJ007 #259909

I’d still love to know WHAT ARE NEXT STEPS if they plan on using sachets for OM in phase 3? Anyone?

blanka

04/09/19 8:50 AM

#259913 RE: PJ007 #259909

LOVE THIS PART!!!


In other news, the Company will commence Scientific Advice discussions with the European Medicines Agency (EMA) this week, via a scheduled meeting, to review plans for the international Phase 3 Brilacidin Oral Mucositis program. Also in the coming weeks, the Company plans to provide an update on its Brilacidin program for the treatment of Inflammatory Bowel Disease.

IPIX